ARNI — Arno Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.01m
- -$2.10m
Annual balance sheet for Arno Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2011 December 31st | 2012 December 31st | 2013 December 31st | 2014 December 31st | 2015 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 6.68 | 10.9 | 26.8 | 7.95 | 0.067 |
| Prepaid Expenses | |||||
| Total Current Assets | 6.98 | 11.1 | 26.9 | 8.21 | 0.328 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.039 | 0.025 | 0.012 | 0.031 | 0.023 |
| Other Long Term Assets | |||||
| Total Assets | 7.02 | 12.9 | 26.9 | 8.25 | 0.361 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1.96 | 3.25 | 3.9 | 2.16 | 4.23 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 5.67 | 25.2 | 39.8 | 8.84 | 8.99 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 1.36 | -12.3 | -12.9 | -0.589 | -8.62 |
| Total Liabilities & Shareholders' Equity | 7.02 | 12.9 | 26.9 | 8.25 | 0.361 |
| Total Common Shares Outstanding |